Lupin informs about press release

14 Jun 2024 Evaluate
Lupin has informed that it enclosed a Press Release regarding completion of an inspection by U.S. FDA of the Company’s Injectable facility in Nagpur, India. The inspection of the facility was carried out from June 10 to June 13, 2024, and concluded with zero 483 observations. 

The above information is a part of company’s filings submitted to BSE.

Lupin Share Price

2083.00 3.50 (0.17%)
30-Dec-2025 11:14 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.20
Dr. Reddys Lab 1268.00
Cipla 1487.25
Zydus Lifesciences 903.15
Lupin 2083.00
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×